Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1300
+0.0100 (8.33%)
Oct 9, 2026, 2:25 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 16.7 million as of October 9, 2026. It is the 40,764th most valuable company in the world and the 1,156th biggest in Australia. Its market cap has decreased by 45.83% in one year.
Market Cap
16.70M
Enterprise Value
10.34M
Revenue
5.48M
Global Rank
Country Rank
#1,156 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has decreased from 19.02M to 16.70M, a decrease of -12.22%. That is a compound annual growth rate of -2.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 16.70M | -55.93% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurotech International | 22.62M |
| Imugene | 20.08M |
| Proteomics International Laboratories | 19.84M |
| Noxopharm | 19.05M |
| Algorae Pharmaceuticals | 18.25M |
| Ceryvyn Therapeutics | 17.78M |
| Patrys | 17.47M |
| EZZ Life Science Holdings | 16.47M |